Literature DB >> 26404441

Non-immune Hemolysis: Diagnostic Considerations.

Photis Beris1, Véronique Picard2.   

Abstract

Non-immune hemolytic anemia (NIHA) is characterized by positive routine hemolytic tests but negative anti-human immunoglobulin (Coombs) test. Hereditary non-immune hemolysis includes disorders of erythrocytic enzymes, membrane, hemoglobin (qualitative and quantitative disorders), as well as the rare hereditary forms of thrombotic microangiopathies. Acquired NIHA includes paroxysmal nocturnal hemolysis (PNH), infections, drug and metal intoxications with as a target red blood cells or endothelium of capillaries, the rare acquired forms of thalassemia or erythrocytic membrane disorders, and hemolysis secondary to a dysfunctioning artificial (prosthetic) cardiac valve. Identification of the specific cause of NIHA is sometimes difficult and requires not only a good knowledge of this entity but mainly a qualified specialized hematologic laboratory. An algorithm to be used in every new patient consulting for NIHA is proposed in the last part of this article.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26404441     DOI: 10.1053/j.seminhematol.2015.07.005

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  3 in total

1.  Severe mechanical hemolysis in a patient with thalassemia minor who had undergone inappropriate splenectomy.

Authors:  Lorenzo Falchi; Lola M Grillo; Jillian L Diuguid-Gerber; Andrew B Eisenberger; Joseph G Jurcic
Journal:  Int J Hematol       Date:  2016-05-20       Impact factor: 2.490

2.  Hemolysis during and after 21 days of head-down-tilt bed rest.

Authors:  Guy Trudel; Hans K Uhthoff; Odette Laneuville
Journal:  Physiol Rep       Date:  2017-12

3.  Genotoxicity and Hemocompatibility of a Novel Calcium Aluminate-Based Cement.

Authors:  Rafael Fernández; Carolina Berruecos; María Catalina Cortés Motta; Diego Velásquez
Journal:  Eur Endod J       Date:  2018-07-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.